Difficulty: Medium
Average Score: 76%
Testbank
A patient with poorly controlled diabetes has developed end-stage renal failure and consequent anemia. When reviewing this patient's treatment plan, the nurse should anticipate the use of what drug?
Correct answer
B
Rationale
Epoetin alfa is a synthetic form of erythropoietin that stimulates red blood cell production, making it essential for treating anemia in patients with end-stage renal failure, particularly in those with poorly controlled diabetes.
A: Magnesium sulfate is primarily used to manage conditions such as eclampsia or severe asthma exacerbations and does not address anemia or renal failure directly.
C: Low-molecular weight heparin is an anticoagulant used to prevent thromboembolism and does not play a role in the management of anemia related to renal failure.
D: Vitamin K is important for blood clotting and is not indicated in treating anemia associated with end-stage renal failure, as it does not stimulate red blood cell production.
A: Magnesium sulfate is primarily used to manage conditions such as eclampsia or severe asthma exacerbations and does not address anemia or renal failure directly.
C: Low-molecular weight heparin is an anticoagulant used to prevent thromboembolism and does not play a role in the management of anemia related to renal failure.
D: Vitamin K is important for blood clotting and is not indicated in treating anemia associated with end-stage renal failure, as it does not stimulate red blood cell production.